In Pakistan, a growing body of clinical research, hospital case series, and on-the-ground testimony from physicians and ...

You might associate autoimmune conditions with symptoms like skin disease, chronic pain, and fatigue. A less-discussed ...

Discover how inflammation peptides are revolutionising our understanding of immune regulation, offering new avenues for ...

Crispr Therapeutics (($CRSP)) announced an update on their ongoing clinical study. Study Overview: The clinical study titled A Phase 1 Dose ...

Weight loss of at least 5% was associated with improvements in PROs among individuals with RMDs taking weight loss medications.

Systemic lupus erythematosus (SLE) is a complex autoimmune disease with a spectrum of very different manifestations and ...

GAAP revenue for Q2 2025 dropped 99.1% from last year to $0.298 million. The pivotal Phase 3 AURORA trial for Descartes-08 in myasthenia gravis started enrolling patients.

Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today reported financial ...

In a surprising discovery, scientists found that lupus symptoms often decline with age due to a natural reduction in immune ...

First patient treated in company-sponsored global basket trial exploring AlloNK® + rituximab in refractory rheumatoid arthritis, Sjögren’s disease, idiopathic inflammatory myopathies, and systemic ...

CLN-978 program now actively enrolling across Phase 1 studies in systemic lupus erythematosus (SLE), rheumatoid arthritis (RA ...

Research and development expenses were $14.9 million for the three months ended June 30, 2025, compared to $12.7 million for the three months ended June 30, 2024. The increase in expenses was ...